User profiles for Craig B. Thompson
Craig ThompsonMemorial Sloan Kettering Cancer Center Verified email at mskcc.org Cited by 263916 |
Understanding the Warburg effect: the metabolic requirements of cell proliferation
MG Vander Heiden, LC Cantley, CB Thompson - science, 2009 - science.org
In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative
phosphorylation to generate the energy needed for cellular processes, most cancer cells instead …
phosphorylation to generate the energy needed for cellular processes, most cancer cells instead …
[PDF][PDF] The biology of cancer: metabolic reprogramming fuels cell growth and proliferation
…, JJ Lum, G Hatzivassiliou, CB Thompson - Cell metabolism, 2008 - cell.com
Cell proliferation requires nutrients, energy, and biosynthetic activity to duplicate all
macromolecular components during each passage through the cell cycle. It is therefore not …
macromolecular components during each passage through the cell cycle. It is therefore not …
[PDF][PDF] The emerging hallmarks of cancer metabolism
NN Pavlova, CB Thompson - Cell metabolism, 2016 - cell.com
Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and
indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism …
indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism …
[PDF][PDF] Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
…, LA Godley, R Delwel, PJM Valk, CB Thompson… - Cancer cell, 2010 - cell.com
Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and
resultant 2-hydroxyglutarate (2HG) production. Mutational and epigenetic profiling of a large …
resultant 2-hydroxyglutarate (2HG) production. Mutational and epigenetic profiling of a large …
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature
of a major subset of primary human brain cancers. These mutations occur at a single amino …
of a major subset of primary human brain cancers. These mutations occur at a single amino …
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in
gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel …
gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel …
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Both genome-wide genetic and epigenetic alterations are fundamentally important for the
development of cancers, but the interdependence of these aberrations is poorly understood. …
development of cancers, but the interdependence of these aberrations is poorly understood. …
Apoptosis in the pathogenesis and treatment of disease
CB Thompson - Science, 1995 - science.org
In multicellular organisms, homeostasis is maintained through a balance between cell
proliferation and cell death. Although much is known about the control of cell proliferation, less is …
proliferation and cell death. Although much is known about the control of cell proliferation, less is …
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
…, SK Tahir, CB Thompson, KJ Tomaselli, B Wang… - Nature, 2005 - nature.com
Proteins in the Bcl-2 family are central regulators of programmed cell death 1 , and members
that inhibit apoptosis, such as Bcl-X L and Bcl-2, are overexpressed in many cancers and …
that inhibit apoptosis, such as Bcl-X L and Bcl-2, are overexpressed in many cancers and …
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death
…, AJ Ross, KA Roth, GR MacGregor, CB Thompson… - Science, 2001 - science.org
Multiple death signals influence mitochondria during apoptosis, yet the critical initiating event
for mitochondrial dysfunction in vivo has been unclear. tBID, the caspase-activated form of …
for mitochondrial dysfunction in vivo has been unclear. tBID, the caspase-activated form of …